Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Bullboard Posts
Comment by Sonny7on Dec 12, 2019 1:09pm
82 Views
Post# 30448423

RE:Little uptick

RE:Little uptickI agree that the tax loss selling is not a valid excuse for this weak share price. Most people might have the idea that timing is not correct for that, considering that trial data news could come in January and the positive news could bite them. 

The company has has no leadership. A scientist with no business sense has been appointed to the position of CEO and he in turn hired a weak narcissistic fool who quickly ran out of experience to deal with anything other than take calls from investors and blatantly lie to them and also passes information to his select few ahead of news so that the potential positive impact of the news is negated with his leaking of insider information that he is privy to. Someone gave this hairball the title of business development officer when in fact, it’s more to the tune of business demolition idiot. He is overpaid to know nothing, meows and belly aches if he has to do any kind of work that his job description may call for, acts like a damn fool in the presence of multi national pharmaceutical dignitaries firing selfies with them in the background and dresses in Don Cherry garb as he struggles through mid life crisis. On top of that he’s not even motivated to learn about his own damn job as he’s overpaid to be there but yet acts as if he’s the final answer and to the degree that he thinks that he’s running the company and too stupid to realize that he’s created this weakness. 

I strongly believe that the institutional holders know that and smell blood and are positioning themselves to own more paper at a price lower than where it is now. At a million dollars per trial subject and with things as they are then they won’t have to wait long. In saying all of this as I see it then the best I and my friends and family involved can do is vote against the things we don’t agree with and hope for the best as we vote ahead of the upcoming AGM. The only thing to save us all would be a pharma deal where the pharmaceutical company laid out some cash for the company to accompany the deal. Does anyone there have the sense to accomplish that? Embarrassing!! A world class company, potentially, and it flounders as a rudderless ship.      my opinion
Bullboard Posts